Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 286–286 | Cite as

Trastuzumab

Nausea and decreased left ventricular ejection fraction: 2 case reports
Case report
  • 6 Downloads

Reference

  1. Yamashiro H, et al. Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. Breast Cancer: Basic and Clinical Research 12: no pagination, 2 Jul 2018. Available from: URL: http://doi.org/10.1177/1178223418786243 - Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations